hey FELLER...good to see you back posting. Missed your DD post buddy.
$3.0 price target on efficacy results is conservative. This psoriasis creme is the only one clinically tested on the market. This could take the psoriasis health sector by storm.
Realistically, I would say the PPS could be from $2.0 to $2.50 range in the run up to the efficacy results. Then it should run at least 100% from there when positive and robust efficacy results are released.
Go $$OWCP$$
All imho, not an investment advice. Do your own DD.
I would expect it to hit $3 on the news, then a sell off as it is digested. The next step will be WHEN sales start and WHAT the projected sales will be. They are tackling a pretty painful skin condition and the market is huge if it works as suspected. Exciting times.